Certara

Certara, founded in 2008, is positioned as a leading consultancy in drug development, with a focus on biotechnology, healthcare, and pharmaceuticals. Headquartered in the United States, the company prides itself on its slogan: "The leading drug development consultancy with solutions spanning the discovery, preclinical and clinical stages of drug development."

The company excels by leveraging its proprietary biosimulation software and technology to streamline and enhance the drug discovery and development process. Serving a diverse clientele consisting of 2,000 biopharmaceutical firms, academic institutions, and regulatory agencies across 62 countries, Certara has established a robust presence in the global market.

Its most recent investment—a grant on 01 August 2023—from the US Food and Drug Administration solidifies its status as a valued partner in the regulatory space, further validating its strategic importance in the industry.